Andrew D. Tustian

666 total citations
17 papers, 508 citations indexed

About

Andrew D. Tustian is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Andrew D. Tustian has authored 17 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Genetics and 3 papers in Infectious Diseases. Recurrent topics in Andrew D. Tustian's work include Virus-based gene therapy research (9 papers), Viral Infectious Diseases and Gene Expression in Insects (9 papers) and Protein purification and stability (5 papers). Andrew D. Tustian is often cited by papers focused on Virus-based gene therapy research (9 papers), Viral Infectious Diseases and Gene Expression in Insects (9 papers) and Protein purification and stability (5 papers). Andrew D. Tustian collaborates with scholars based in United States, United Kingdom and Sweden. Andrew D. Tustian's co-authors include Hanne Bak, Benjamin Adams, Frank Cordes, Mark S.P. Sansom, Wolfgang B. Fischer, Nicholas Papadopoulos, Bindu Varghese, Samuel Davis, Jessica R. Kirshner and George D. Yancopoulos and has published in prestigious journals such as Analytical Chemistry, Biochemistry and Scientific Reports.

In The Last Decade

Andrew D. Tustian

16 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew D. Tustian United States 11 368 230 122 121 73 17 508
Rahel Frick United States 11 251 0.7× 261 1.1× 48 0.4× 29 0.2× 144 2.0× 16 462
Tiziano Gaiotto United States 10 221 0.6× 203 0.9× 22 0.2× 16 0.1× 93 1.3× 12 407
No Soo Kim South Korea 9 641 1.7× 130 0.6× 58 0.5× 258 2.1× 26 0.4× 10 663
Natalie Müller Switzerland 8 435 1.2× 89 0.4× 70 0.6× 207 1.7× 37 0.5× 13 573
Dana Haddad United States 14 136 0.4× 35 0.2× 217 1.8× 319 2.6× 54 0.7× 29 488
Lucas H. Horan United States 6 339 0.9× 19 0.1× 163 1.3× 58 0.5× 211 2.9× 9 574
Stefania Carrara Germany 10 126 0.3× 108 0.5× 91 0.7× 27 0.2× 62 0.8× 30 317
Hoyin Mok United States 8 336 0.9× 37 0.2× 122 1.0× 318 2.6× 42 0.6× 10 465
Laurent Chevalet Switzerland 8 248 0.7× 106 0.5× 33 0.3× 60 0.5× 85 1.2× 10 363
Sofia B. Carvalho Portugal 12 282 0.8× 53 0.2× 26 0.2× 59 0.5× 52 0.7× 18 376

Countries citing papers authored by Andrew D. Tustian

Since Specialization
Citations

This map shows the geographic impact of Andrew D. Tustian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Tustian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Tustian more than expected).

Fields of papers citing papers by Andrew D. Tustian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Tustian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Tustian. The network helps show where Andrew D. Tustian may publish in the future.

Co-authorship network of co-authors of Andrew D. Tustian

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Tustian. A scholar is included among the top collaborators of Andrew D. Tustian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Tustian. Andrew D. Tustian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Reeves, John Τ., et al.. (2025). Development of cell-based assay for detecting replication-competent adeno-associated virus by qPCR. Molecular Therapy — Methods & Clinical Development. 33(3). 101529–101529.
2.
Thakur, Garima, et al.. (2025). A two-pass anion-exchange chromatography strategy for enrichment of full capsids in manufacturing of adeno-associated viral vectors. Molecular Therapy — Methods & Clinical Development. 33(2). 101441–101441. 3 indexed citations
3.
Thakur, Garima, Sheldon Mink, Hanne Bak, & Andrew D. Tustian. (2024). Single-use chromatographic clarification to eliminate endonuclease treatment in production of recombinant adeno-associated viral vectors. Separation and Purification Technology. 354. 128557–128557. 3 indexed citations
4.
Thakur, Garima, Sheldon Mink, Hanne Bak, & Andrew D. Tustian. (2024). Improving process efficiency to reduce cost-of-goods per dose in manufacturing of recombinant AAVs. Cell and Gene Therapy Insights. 10(3). 479–499. 1 indexed citations
5.
Zhang, Zhe, et al.. (2024). High‐yield recombinant adeno‐associated viral vector production by multivariate optimization of bioprocess and transfection conditions. Biotechnology Progress. 40(3). e3445–e3445. 12 indexed citations
6.
Thakur, Garima, Sheldon Mink, Hanne Bak, & Andrew D. Tustian. (2023). Opportunities to implement continuous processing in production of recombinant adeno-associated viral vectors. Cell and Gene Therapy Insights. 9(3). 563–579–563–579. 2 indexed citations
7.
Tustian, Andrew D., et al.. (2023). Optimizing ddPCR assay for characterizing AAV vector genome integrity. Cell and Gene Therapy Insights. 9(7). 867–876. 2 indexed citations
8.
9.
Tustian, Andrew D. & Hanne Bak. (2021). Assessment of quality attributes for adeno‐associated viral vectors. Biotechnology and Bioengineering. 118(11). 4186–4203. 37 indexed citations
10.
Xiao, Hui, Michael A. Goren, Darya Burakov, et al.. (2020). Putative Phospholipase B-Like 2 is Not Responsible for Polysorbate Degradation in Monoclonal Antibody Drug Products. Journal of Pharmaceutical Sciences. 109(9). 2710–2718. 29 indexed citations
11.
Adams, Benjamin, Hanne Bak, & Andrew D. Tustian. (2020). Moving from the bench towards a large scale, industrial platform process for adeno‐associated viral vector purification. Biotechnology and Bioengineering. 117(10). 3199–3211. 60 indexed citations
12.
Tustian, Andrew D., et al.. (2018). Development of a novel affinity chromatography resin for platform purification of bispecific antibodies with modified protein a binding avidity. Biotechnology Progress. 34(3). 650–658. 21 indexed citations
13.
14.
Smith, Eric, Kara Olson, Lauric Haber, et al.. (2015). A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys. Scientific Reports. 5(1). 17943–17943. 122 indexed citations
15.
Dutta, Amit Kumar, et al.. (2015). Purification of monoclonal antibodies from clarified cell culture fluid using Protein A capture continuous countercurrent tangential chromatography. Journal of Biotechnology. 213. 54–64. 36 indexed citations
16.
Tustian, Andrew D., et al.. (2007). Adapted Ultra Scale‐Down Approach for Predicting the Centrifugal Separation Behavior of High Cell Density Cultures. Biotechnology Progress. 23(6). 1404–1410. 28 indexed citations
17.
Cordes, Frank, et al.. (2002). Bundles Consisting of Extended Transmembrane Segments of Vpu from HIV-1:  Computer Simulations and Conductance Measurements. Biochemistry. 41(23). 7359–7365. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rahel Frick Breakdown of academic impact, for papers by Tiziano Gaiotto Breakdown of academic impact, for papers by No Soo Kim Breakdown of academic impact, for papers by Natalie Müller Breakdown of academic impact, for papers by Dana Haddad Breakdown of academic impact, for papers by Lucas H. Horan Breakdown of academic impact, for papers by Stefania Carrara Breakdown of academic impact, for papers by Hoyin Mok Breakdown of academic impact, for papers by Laurent Chevalet Breakdown of academic impact, for papers by Sofia B. Carvalho
Rankless by CCL
2026